cececinok personal page - To The Moon

cececinok

cececinok

No personal profile

60Follow

3Followers

3Topic

0Badge

02-13

$CHINAAMC SELECT FIXED INCOME ALLOCATION "A" (USD) ACC(HK0000439601.USD)$

02-04

$Charisma Energy(YSV.SI)$

04-13 13:53

$HSTECH(HSTECH)$ 100

01-23

Join me on Tiger Trade!

$Xiaomi Corp.(XIACY)$ Find out more here:Join me on Tiger Trade! Sign up with my invite and we receive rewards valued at HK$1,800*!

Join me on Tiger Trade!

01-15

Nica

01-30

Great article, would you like to share it?

Regeneron Pharma 4Q Profit Falls as Higher R&D Weighs

04-01

$CHINAAMC SELECT FIXED INCOME ALLOCATION "A" (USD) ACC(HK0000439601.USD)$

02-02

$ChinaAMC Select Greater China Technology Fund Class A HKD(HK0000165453.HKD)$

01-22

Nice

Sorry, the original content has been removed

01-21

$Netflix(NFLX)$

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4231039849485302","uuid":"4231039849485302","gmtCreate":1767935828774,"gmtModify":1768527027698,"name":"cececinok","pinyin":"cececinok","introduction":"","introductionEn":null,"signature":"","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":60,"tweetSize":24,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":3,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":11,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":553159493919184,"gmtCreate":1776059580064,"gmtModify":1776059582688,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/HSTECH\">$HSTECH(HSTECH)$&nbsp;</a> 100","listText":"<a href=\"https://ttm.financial/S/HSTECH\">$HSTECH(HSTECH)$&nbsp;</a> 100","text":"$HSTECH(HSTECH)$ 100","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/553159493919184","isVote":1,"tweetType":1,"viewCount":8,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":548939102209688,"gmtCreate":1775039430111,"gmtModify":1775039432840,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/FUND/HK0000439601.USD\">$CHINAAMC SELECT FIXED INCOME ALLOCATION \"A\" (USD) ACC(HK0000439601.USD)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/FUND/HK0000439601.USD\">$CHINAAMC SELECT FIXED INCOME ALLOCATION \"A\" (USD) ACC(HK0000439601.USD)$ </a>&nbsp;","text":"$CHINAAMC SELECT FIXED INCOME ALLOCATION \"A\" (USD) ACC(HK0000439601.USD)$","images":[{"img":"https://community-static.tradeup.com/news/280e39246759f5914c7e552e464fc3a1","width":"1220","height":"2736"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/548939102209688","isVote":1,"tweetType":1,"viewCount":62,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":532368851559392,"gmtCreate":1770994427660,"gmtModify":1770994430046,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/FUND/HK0000439601.USD\">$CHINAAMC SELECT FIXED INCOME ALLOCATION \"A\" (USD) ACC(HK0000439601.USD)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/FUND/HK0000439601.USD\">$CHINAAMC SELECT FIXED INCOME ALLOCATION \"A\" (USD) ACC(HK0000439601.USD)$ </a>&nbsp;","text":"$CHINAAMC SELECT FIXED INCOME ALLOCATION \"A\" (USD) ACC(HK0000439601.USD)$","images":[{"img":"https://community-static.tradeup.com/news/76e455044574adba928c8edf94b65188","width":"1220","height":"2736"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/532368851559392","isVote":1,"tweetType":1,"viewCount":468,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":529165232550264,"gmtCreate":1770212866671,"gmtModify":1770212869782,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/YSV.SI\">$Charisma Energy(YSV.SI)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/YSV.SI\">$Charisma Energy(YSV.SI)$ </a>&nbsp;","text":"$Charisma Energy(YSV.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/529165232550264","isVote":1,"tweetType":1,"viewCount":768,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":528458500056328,"gmtCreate":1770040376032,"gmtModify":1770040378419,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/FUND/HK0000165453.HKD\">$ChinaAMC Select Greater China Technology Fund Class A HKD(HK0000165453.HKD)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/FUND/HK0000165453.HKD\">$ChinaAMC Select Greater China Technology Fund Class A HKD(HK0000165453.HKD)$ </a>&nbsp;","text":"$ChinaAMC Select Greater China Technology Fund Class A HKD(HK0000165453.HKD)$","images":[{"img":"https://community-static.tradeup.com/news/211d4de4d08b6277894fa44916e68d20","width":"1220","height":"2488"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/528458500056328","isVote":1,"tweetType":1,"viewCount":572,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":527377812034664,"gmtCreate":1769776528618,"gmtModify":1769776532029,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/527377812034664","repostId":"2607017465","repostType":4,"repost":{"id":"2607017465","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1769776369,"share":"https://ttm.financial/m/news/2607017465?lang=en_US&edition=fundamental","pubTime":"2026-01-30 20:32","market":"us","language":"en","title":"Regeneron Pharma 4Q Profit Falls as Higher R&D Weighs","url":"https://stock-news.laohu8.com/highlight/detail?id=2607017465","media":"Dow Jones","summary":"Regeneron Pharmaceuticals profit fell in the fourth quarter, despite higher revenue, on the back of higher research-and-development expenses.","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a> profit fell in the fourth quarter, despite higher revenue, on the back of higher research-and-development expenses.</p><p>The biotechnology company posted on Friday a lower net income of $845 million, or $7.86 a share, compared with $918 million, or $8.06 a share, in the same quarter a year earlier.</p><p>Adjusted earnings came to $11.44 a share. According to FactSet, analysts were expecting $10.74 a share.</p><p>Total revenue rose 3% to $3.88 billion, topping analyst forecasts of $3.81 billion.</p><p>R&amp;D expenses rose 15% to $1.63 billion in the quarter.</p><p>For 2026, Regeneron estimates R&amp;D expenses to be in the range of $6.45 billion to $6.68 billion, and when adjusting for stock-based compensation expenses, the range is forecasted at between $5.9 billion and $6.1 billion.</p><p>Chief Financial Officer Christopher Fenimore said the company&#39;s priorities this year remain on internal investments, evaluating complementary business-development opportunities, and capital returns through share repurchases and dividends.</p><p>Shares were down 2.1% to $733.49 in premarket trading.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/2a494c4fcad22c7ec2e44e4ccfb1e917\" tg-width=\"537\" tg-height=\"158\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron Pharma 4Q Profit Falls as Higher R&D Weighs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron Pharma 4Q Profit Falls as Higher R&D Weighs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-30 20:32</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a> profit fell in the fourth quarter, despite higher revenue, on the back of higher research-and-development expenses.</p><p>The biotechnology company posted on Friday a lower net income of $845 million, or $7.86 a share, compared with $918 million, or $8.06 a share, in the same quarter a year earlier.</p><p>Adjusted earnings came to $11.44 a share. According to FactSet, analysts were expecting $10.74 a share.</p><p>Total revenue rose 3% to $3.88 billion, topping analyst forecasts of $3.81 billion.</p><p>R&amp;D expenses rose 15% to $1.63 billion in the quarter.</p><p>For 2026, Regeneron estimates R&amp;D expenses to be in the range of $6.45 billion to $6.68 billion, and when adjusting for stock-based compensation expenses, the range is forecasted at between $5.9 billion and $6.1 billion.</p><p>Chief Financial Officer Christopher Fenimore said the company&#39;s priorities this year remain on internal investments, evaluating complementary business-development opportunities, and capital returns through share repurchases and dividends.</p><p>Shares were down 2.1% to $733.49 in premarket trading.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/2a494c4fcad22c7ec2e44e4ccfb1e917\" tg-width=\"537\" tg-height=\"158\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LU1917777945.USD":"安联专题基金Cl AT Acc","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU0882574055.USD":"富达全球健康医疗A ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BK4585":"ETF&股票定投概念","REGN":"再生元制药公司","BK4139":"生物科技","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","BK4588":"碎股","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC"},"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2607017465","content_text":"Regeneron Pharmaceuticals profit fell in the fourth quarter, despite higher revenue, on the back of higher research-and-development expenses.The biotechnology company posted on Friday a lower net income of $845 million, or $7.86 a share, compared with $918 million, or $8.06 a share, in the same quarter a year earlier.Adjusted earnings came to $11.44 a share. According to FactSet, analysts were expecting $10.74 a share.Total revenue rose 3% to $3.88 billion, topping analyst forecasts of $3.81 billion.R&D expenses rose 15% to $1.63 billion in the quarter.For 2026, Regeneron estimates R&D expenses to be in the range of $6.45 billion to $6.68 billion, and when adjusting for stock-based compensation expenses, the range is forecasted at between $5.9 billion and $6.1 billion.Chief Financial Officer Christopher Fenimore said the company's priorities this year remain on internal investments, evaluating complementary business-development opportunities, and capital returns through share repurchases and dividends.Shares were down 2.1% to $733.49 in premarket trading.","news_type":1,"symbols_score_info":{"REGN":0.9}},"isVote":1,"tweetType":1,"viewCount":1047,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":525252986835472,"gmtCreate":1769261515602,"gmtModify":1769261517920,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/FUND/HK0000165453.HKD\">$ChinaAMC Select Greater China Technology Fund Class A HKD(HK0000165453.HKD)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/FUND/HK0000165453.HKD\">$ChinaAMC Select Greater China Technology Fund Class A HKD(HK0000165453.HKD)$ </a>&nbsp;","text":"$ChinaAMC Select Greater China Technology Fund Class A HKD(HK0000165453.HKD)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/525252986835472","isVote":1,"tweetType":1,"viewCount":1178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":524749489620056,"gmtCreate":1769138706373,"gmtModify":1769138708587,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/FUT/YMmain\">$E-mini Dow Jones - main 2603(YMmain)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/FUT/YMmain\">$E-mini Dow Jones - main 2603(YMmain)$&nbsp;</a>&nbsp;","text":"$E-mini Dow Jones - main 2603(YMmain)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524749489620056","repostId":"2605405794","repostType":4,"repost":{"id":"2605405794","kind":"live","pubTimestamp":1769137807,"share":"https://ttm.financial/m/news/2605405794?lang=en_US&edition=fundamental","pubTime":"2026-01-23 11:10","market":"nz","language":"en","title":"BOJ Maintains Short-Term Interest Rate Target Unchanged at 0.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605405794","media":"THOMSON REUTERS","summary":"BOJ Maintains Short-Term Interest Rate Target Unchanged at 0.75%","content":"<html><head></head><body><p>BOJ Maintains Short-Term Interest Rate Target Unchanged at 0.75%</p></body></html>","source":"reuters_en_live","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BOJ Maintains Short-Term Interest Rate Target Unchanged at 0.75%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBOJ Maintains Short-Term Interest Rate Target Unchanged at 0.75%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-23 11:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260123:nP8N3Y70EZ:1><strong>THOMSON REUTERS</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BOJ Maintains Short-Term Interest Rate Target Unchanged at 0.75%</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260123:nP8N3Y70EZ:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index"},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260123:nP8N3Y70EZ:1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2605405794","content_text":"BOJ Maintains Short-Term Interest Rate Target Unchanged at 0.75%","news_type":1,"symbols_score_info":{".SPX":2}},"isVote":1,"tweetType":1,"viewCount":1260,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":524731392476656,"gmtCreate":1769134190793,"gmtModify":1769134706049,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"Join me on Tiger Trade!","htmlText":"<a href=\"https://ttm.financial/S/XIACY\">$Xiaomi Corp.(XIACY)$&nbsp;</a>&nbsp;Find out more here:<a href=\"https://tigr.link/s/20DjD5R\">Join me on Tiger Trade!</a> Sign up with my invite and we receive rewards valued at HK$1,800*!","listText":"<a href=\"https://ttm.financial/S/XIACY\">$Xiaomi Corp.(XIACY)$&nbsp;</a>&nbsp;Find out more here:<a href=\"https://tigr.link/s/20DjD5R\">Join me on Tiger Trade!</a> Sign up with my invite and we receive rewards valued at HK$1,800*!","text":"$Xiaomi Corp.(XIACY)$ Find out more here:Join me on Tiger Trade! Sign up with my invite and we receive rewards valued at HK$1,800*!","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524731392476656","isVote":1,"tweetType":1,"viewCount":1104,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":524526219838520,"gmtCreate":1769084181172,"gmtModify":1769084184305,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524526219838520","repostId":"1180171877","repostType":4,"isVote":1,"tweetType":1,"viewCount":1022,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":524493177168800,"gmtCreate":1769076106642,"gmtModify":1769076109933,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/YSV.SI\">$Charisma Energy(YSV.SI)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/YSV.SI\">$Charisma Energy(YSV.SI)$ </a>&nbsp;","text":"$Charisma Energy(YSV.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524493177168800","repostId":"1101751051","repostType":4,"repost":{"id":"1101751051","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1769075537,"share":"https://ttm.financial/m/news/1101751051?lang=en_US&edition=fundamental","pubTime":"2026-01-22 17:52","market":"us","language":"en","title":"Moderna Soars over 5% on Positive Cancer Therapy Results and Analyst Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=1101751051","media":"Tiger Newspress","summary":"Moderna, Inc. (MRNA) saw its stock price soar 5.22% in pre-market trading, continuing its strong momentum from the previous session.The surge is driven by positive clinical trial results for...","content":"<html><head></head><body><p><strong><a href=\"https://laohu8.com/S/MRNA\">Moderna</a></strong> saw its stock price soar 5.12% in pre-market trading, continuing its strong momentum from the previous session. The surge is driven by positive clinical trial results for Moderna&#39;s experimental skin cancer vaccine developed in collaboration with Merck &amp; Co. The Phase 2b study showed that adding Moderna&#39;s intismeran autogene to KEYTRUDA significantly reduced the risk of recurrence or death in melanoma patients, with sustained benefits over five years.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/ee9106001efd353ae27ce6002ed65d10\" tg-width=\"876\" tg-height=\"603\"/></p><p>Additionally, Bernstein raised Moderna&#39;s target price to $35 from $25, reflecting increased confidence in the company&#39;s growth trajectory. These developments have fueled investor optimism, leading to the stock&#39;s pre-market rally.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Soars over 5% on Positive Cancer Therapy Results and Analyst Upgrade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Soars over 5% on Positive Cancer Therapy Results and Analyst Upgrade\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2026-01-22 17:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><strong><a href=\"https://laohu8.com/S/MRNA\">Moderna</a></strong> saw its stock price soar 5.12% in pre-market trading, continuing its strong momentum from the previous session. The surge is driven by positive clinical trial results for Moderna&#39;s experimental skin cancer vaccine developed in collaboration with Merck &amp; Co. The Phase 2b study showed that adding Moderna&#39;s intismeran autogene to KEYTRUDA significantly reduced the risk of recurrence or death in melanoma patients, with sustained benefits over five years.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/ee9106001efd353ae27ce6002ed65d10\" tg-width=\"876\" tg-height=\"603\"/></p><p>Additionally, Bernstein raised Moderna&#39;s target price to $35 from $25, reflecting increased confidence in the company&#39;s growth trajectory. These developments have fueled investor optimism, leading to the stock&#39;s pre-market rally.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101751051","content_text":"Moderna saw its stock price soar 5.12% in pre-market trading, continuing its strong momentum from the previous session. The surge is driven by positive clinical trial results for Moderna's experimental skin cancer vaccine developed in collaboration with Merck & Co. The Phase 2b study showed that adding Moderna's intismeran autogene to KEYTRUDA significantly reduced the risk of recurrence or death in melanoma patients, with sustained benefits over five years.Additionally, Bernstein raised Moderna's target price to $35 from $25, reflecting increased confidence in the company's growth trajectory. These developments have fueled investor optimism, leading to the stock's pre-market rally.","news_type":1,"symbols_score_info":{"MRNA":1}},"isVote":1,"tweetType":1,"viewCount":1396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":524197282705768,"gmtCreate":1769003772117,"gmtModify":1769003774251,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/FUT/YMmain\">$E-mini Dow Jones - main 2603(YMmain)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/FUT/YMmain\">$E-mini Dow Jones - main 2603(YMmain)$&nbsp;</a>&nbsp;","text":"$E-mini Dow Jones - main 2603(YMmain)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524197282705768","isVote":1,"tweetType":1,"viewCount":1139,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":524186777727560,"gmtCreate":1769001210951,"gmtModify":1769001213882,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/ZSL\">$Proshares Ultrashort Silver(ZSL)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/ZSL\">$Proshares Ultrashort Silver(ZSL)$ </a>&nbsp;","text":"$Proshares Ultrashort Silver(ZSL)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524186777727560","isVote":1,"tweetType":1,"viewCount":691,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":524175023068144,"gmtCreate":1768998352263,"gmtModify":1768998355612,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/WDC\">$Western Digital(WDC)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/WDC\">$Western Digital(WDC)$&nbsp;</a>&nbsp;","text":"$Western Digital(WDC)$","images":[{"img":"https://community-static.tradeup.com/news/dac1a4e328228effd3ead57de345a4f7","width":"1006","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524175023068144","isVote":1,"tweetType":1,"viewCount":807,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":524151200810544,"gmtCreate":1768992548152,"gmtModify":1768992551337,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/NFLX\">$Netflix(NFLX)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/NFLX\">$Netflix(NFLX)$ </a>&nbsp;","text":"$Netflix(NFLX)$","images":[{"img":"https://community-static.tradeup.com/news/d3a8f90d712f943bab0ba8f2400077d8","width":"1220","height":"2436"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524151200810544","isVote":1,"tweetType":1,"viewCount":573,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":524106029380384,"gmtCreate":1768981505701,"gmtModify":1768981508392,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/ZSL\">$Proshares Ultrashort Silver(ZSL)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/ZSL\">$Proshares Ultrashort Silver(ZSL)$ </a>&nbsp;","text":"$Proshares Ultrashort Silver(ZSL)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524106029380384","repostId":"1180231628","repostType":4,"repost":{"id":"1180231628","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1768980479,"share":"https://ttm.financial/m/news/1180231628?lang=en_US&edition=fundamental","pubTime":"2026-01-21 15:27","market":"us","language":"en","title":"U.S. Natural Gas Futures Surge 23%, United States Natural Ga","url":"https://stock-news.laohu8.com/highlight/detail?id=1180231628","media":"Tiger Newspress","summary":"U.S. Natural Gas Futures Surge 23%, United States Natural Gas Fund(UNG) Soars 9% in Overnight Tradin","content":"U.S. Natural Gas Futures Surge 23%, United States Natural Gas Fund(UNG) Soars 9% in Overnight Trading","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Natural Gas Futures Surge 23%, United States Natural Ga</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Natural Gas Futures Surge 23%, United States Natural Ga\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2026-01-21 15:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\nU.S. Natural Gas Futures Surge 23%, United States Natural Gas Fund(UNG) Soars 9% in Overnight Trading\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180231628","content_text":"U.S. Natural Gas Futures Surge 23%, United States Natural Gas Fund(UNG) Soars 9% in Overnight Trading","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":635,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":524105697556032,"gmtCreate":1768981445564,"gmtModify":1768981447439,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/U/3560184106659134\">@Shernice軒嬣 2000 </a>&nbsp;","listText":"<a href=\"https://ttm.financial/U/3560184106659134\">@Shernice軒嬣 2000 </a>&nbsp;","text":"@Shernice軒嬣 2000","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524105697556032","isVote":1,"tweetType":1,"viewCount":725,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":524105646531896,"gmtCreate":1768981416747,"gmtModify":1768981419196,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/FUT/YMmain\">$E-mini Dow Jones - main 2603(YMmain)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/FUT/YMmain\">$E-mini Dow Jones - main 2603(YMmain)$&nbsp;</a>&nbsp;","text":"$E-mini Dow Jones - main 2603(YMmain)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524105646531896","isVote":1,"tweetType":1,"viewCount":509,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":523678446880328,"gmtCreate":1768877932839,"gmtModify":1768877935045,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/HSI\">$HSI(HSI)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/XAGUSD.FOREX\">$XAG/USD(XAGUSD.FOREX)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/HSI\">$HSI(HSI)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/XAGUSD.FOREX\">$XAG/USD(XAGUSD.FOREX)$&nbsp;</a>&nbsp;","text":"$HSI(HSI)$ $XAG/USD(XAGUSD.FOREX)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/523678446880328","isVote":1,"tweetType":1,"viewCount":1039,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":523677840323928,"gmtCreate":1768877881780,"gmtModify":1768877883797,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4231039849485302","authorIdStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/HSI\">$HSI(HSI)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/XYZ\">$Block, Inc.(XYZ)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/HSI\">$HSI(HSI)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/XYZ\">$Block, Inc.(XYZ)$ </a>&nbsp;","text":"$HSI(HSI)$ $Block, Inc.(XYZ)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/523677840323928","isVote":1,"tweetType":1,"viewCount":350,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":532368851559392,"gmtCreate":1770994427660,"gmtModify":1770994430046,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4231039849485302","idStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/FUND/HK0000439601.USD\">$CHINAAMC SELECT FIXED INCOME ALLOCATION \"A\" (USD) ACC(HK0000439601.USD)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/FUND/HK0000439601.USD\">$CHINAAMC SELECT FIXED INCOME ALLOCATION \"A\" (USD) ACC(HK0000439601.USD)$ </a>&nbsp;","text":"$CHINAAMC SELECT FIXED INCOME ALLOCATION \"A\" (USD) ACC(HK0000439601.USD)$","images":[{"img":"https://community-static.tradeup.com/news/76e455044574adba928c8edf94b65188","width":"1220","height":"2736"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/532368851559392","isVote":1,"tweetType":1,"viewCount":468,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":529165232550264,"gmtCreate":1770212866671,"gmtModify":1770212869782,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4231039849485302","idStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/YSV.SI\">$Charisma Energy(YSV.SI)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/YSV.SI\">$Charisma Energy(YSV.SI)$ </a>&nbsp;","text":"$Charisma Energy(YSV.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/529165232550264","isVote":1,"tweetType":1,"viewCount":768,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":553159493919184,"gmtCreate":1776059580064,"gmtModify":1776059582688,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4231039849485302","idStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/HSTECH\">$HSTECH(HSTECH)$&nbsp;</a> 100","listText":"<a href=\"https://ttm.financial/S/HSTECH\">$HSTECH(HSTECH)$&nbsp;</a> 100","text":"$HSTECH(HSTECH)$ 100","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/553159493919184","isVote":1,"tweetType":1,"viewCount":8,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":524731392476656,"gmtCreate":1769134190793,"gmtModify":1769134706049,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4231039849485302","idStr":"4231039849485302"},"themes":[],"title":"Join me on Tiger Trade!","htmlText":"<a href=\"https://ttm.financial/S/XIACY\">$Xiaomi Corp.(XIACY)$&nbsp;</a>&nbsp;Find out more here:<a href=\"https://tigr.link/s/20DjD5R\">Join me on Tiger Trade!</a> Sign up with my invite and we receive rewards valued at HK$1,800*!","listText":"<a href=\"https://ttm.financial/S/XIACY\">$Xiaomi Corp.(XIACY)$&nbsp;</a>&nbsp;Find out more here:<a href=\"https://tigr.link/s/20DjD5R\">Join me on Tiger Trade!</a> Sign up with my invite and we receive rewards valued at HK$1,800*!","text":"$Xiaomi Corp.(XIACY)$ Find out more here:Join me on Tiger Trade! Sign up with my invite and we receive rewards valued at HK$1,800*!","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524731392476656","isVote":1,"tweetType":1,"viewCount":1104,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":521908519846480,"gmtCreate":1768454283795,"gmtModify":1768454317329,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4231039849485302","idStr":"4231039849485302"},"themes":[],"htmlText":"Nica","listText":"Nica","text":"Nica","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/521908519846480","isVote":1,"tweetType":1,"viewCount":592,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":527377812034664,"gmtCreate":1769776528618,"gmtModify":1769776532029,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4231039849485302","idStr":"4231039849485302"},"themes":[],"title":"","htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/527377812034664","repostId":"2607017465","repostType":4,"repost":{"id":"2607017465","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1769776369,"share":"https://ttm.financial/m/news/2607017465?lang=en_US&edition=fundamental","pubTime":"2026-01-30 20:32","market":"us","language":"en","title":"Regeneron Pharma 4Q Profit Falls as Higher R&D Weighs","url":"https://stock-news.laohu8.com/highlight/detail?id=2607017465","media":"Dow Jones","summary":"Regeneron Pharmaceuticals profit fell in the fourth quarter, despite higher revenue, on the back of higher research-and-development expenses.","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a> profit fell in the fourth quarter, despite higher revenue, on the back of higher research-and-development expenses.</p><p>The biotechnology company posted on Friday a lower net income of $845 million, or $7.86 a share, compared with $918 million, or $8.06 a share, in the same quarter a year earlier.</p><p>Adjusted earnings came to $11.44 a share. According to FactSet, analysts were expecting $10.74 a share.</p><p>Total revenue rose 3% to $3.88 billion, topping analyst forecasts of $3.81 billion.</p><p>R&amp;D expenses rose 15% to $1.63 billion in the quarter.</p><p>For 2026, Regeneron estimates R&amp;D expenses to be in the range of $6.45 billion to $6.68 billion, and when adjusting for stock-based compensation expenses, the range is forecasted at between $5.9 billion and $6.1 billion.</p><p>Chief Financial Officer Christopher Fenimore said the company&#39;s priorities this year remain on internal investments, evaluating complementary business-development opportunities, and capital returns through share repurchases and dividends.</p><p>Shares were down 2.1% to $733.49 in premarket trading.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/2a494c4fcad22c7ec2e44e4ccfb1e917\" tg-width=\"537\" tg-height=\"158\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron Pharma 4Q Profit Falls as Higher R&D Weighs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron Pharma 4Q Profit Falls as Higher R&D Weighs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-30 20:32</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a> profit fell in the fourth quarter, despite higher revenue, on the back of higher research-and-development expenses.</p><p>The biotechnology company posted on Friday a lower net income of $845 million, or $7.86 a share, compared with $918 million, or $8.06 a share, in the same quarter a year earlier.</p><p>Adjusted earnings came to $11.44 a share. According to FactSet, analysts were expecting $10.74 a share.</p><p>Total revenue rose 3% to $3.88 billion, topping analyst forecasts of $3.81 billion.</p><p>R&amp;D expenses rose 15% to $1.63 billion in the quarter.</p><p>For 2026, Regeneron estimates R&amp;D expenses to be in the range of $6.45 billion to $6.68 billion, and when adjusting for stock-based compensation expenses, the range is forecasted at between $5.9 billion and $6.1 billion.</p><p>Chief Financial Officer Christopher Fenimore said the company&#39;s priorities this year remain on internal investments, evaluating complementary business-development opportunities, and capital returns through share repurchases and dividends.</p><p>Shares were down 2.1% to $733.49 in premarket trading.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/2a494c4fcad22c7ec2e44e4ccfb1e917\" tg-width=\"537\" tg-height=\"158\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LU1917777945.USD":"安联专题基金Cl AT Acc","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU0882574055.USD":"富达全球健康医疗A ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BK4585":"ETF&股票定投概念","REGN":"再生元制药公司","BK4139":"生物科技","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","BK4588":"碎股","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC"},"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2607017465","content_text":"Regeneron Pharmaceuticals profit fell in the fourth quarter, despite higher revenue, on the back of higher research-and-development expenses.The biotechnology company posted on Friday a lower net income of $845 million, or $7.86 a share, compared with $918 million, or $8.06 a share, in the same quarter a year earlier.Adjusted earnings came to $11.44 a share. According to FactSet, analysts were expecting $10.74 a share.Total revenue rose 3% to $3.88 billion, topping analyst forecasts of $3.81 billion.R&D expenses rose 15% to $1.63 billion in the quarter.For 2026, Regeneron estimates R&D expenses to be in the range of $6.45 billion to $6.68 billion, and when adjusting for stock-based compensation expenses, the range is forecasted at between $5.9 billion and $6.1 billion.Chief Financial Officer Christopher Fenimore said the company's priorities this year remain on internal investments, evaluating complementary business-development opportunities, and capital returns through share repurchases and dividends.Shares were down 2.1% to $733.49 in premarket trading.","news_type":1,"symbols_score_info":{"REGN":0.9}},"isVote":1,"tweetType":1,"viewCount":1047,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":548939102209688,"gmtCreate":1775039430111,"gmtModify":1775039432840,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4231039849485302","idStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/FUND/HK0000439601.USD\">$CHINAAMC SELECT FIXED INCOME ALLOCATION \"A\" (USD) ACC(HK0000439601.USD)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/FUND/HK0000439601.USD\">$CHINAAMC SELECT FIXED INCOME ALLOCATION \"A\" (USD) ACC(HK0000439601.USD)$ </a>&nbsp;","text":"$CHINAAMC SELECT FIXED INCOME ALLOCATION \"A\" (USD) ACC(HK0000439601.USD)$","images":[{"img":"https://community-static.tradeup.com/news/280e39246759f5914c7e552e464fc3a1","width":"1220","height":"2736"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/548939102209688","isVote":1,"tweetType":1,"viewCount":62,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":528458500056328,"gmtCreate":1770040376032,"gmtModify":1770040378419,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4231039849485302","idStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/FUND/HK0000165453.HKD\">$ChinaAMC Select Greater China Technology Fund Class A HKD(HK0000165453.HKD)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/FUND/HK0000165453.HKD\">$ChinaAMC Select Greater China Technology Fund Class A HKD(HK0000165453.HKD)$ </a>&nbsp;","text":"$ChinaAMC Select Greater China Technology Fund Class A HKD(HK0000165453.HKD)$","images":[{"img":"https://community-static.tradeup.com/news/211d4de4d08b6277894fa44916e68d20","width":"1220","height":"2488"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/528458500056328","isVote":1,"tweetType":1,"viewCount":572,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":524526219838520,"gmtCreate":1769084181172,"gmtModify":1769084184305,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4231039849485302","idStr":"4231039849485302"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524526219838520","repostId":"1180171877","repostType":4,"isVote":1,"tweetType":1,"viewCount":1022,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":524151200810544,"gmtCreate":1768992548152,"gmtModify":1768992551337,"author":{"id":"4231039849485302","authorId":"4231039849485302","name":"cececinok","avatar":"https://community-static.tradeup.com/news/4bf39702e227104035d81ab1d9e856e9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4231039849485302","idStr":"4231039849485302"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/NFLX\">$Netflix(NFLX)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/NFLX\">$Netflix(NFLX)$ </a>&nbsp;","text":"$Netflix(NFLX)$","images":[{"img":"https://community-static.tradeup.com/news/d3a8f90d712f943bab0ba8f2400077d8","width":"1220","height":"2436"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524151200810544","isVote":1,"tweetType":1,"viewCount":573,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}